A systematic review of the efficacy of traditional Chinese medicine retention enema in the treatment of ulcerative colitis

The objective of this study is to summarize the efficacy and safety of traditional Chinese medicine(TCM)enema in the treatment of ulcerative colitis(UC).The randomized controlled trials on TCM enema intervention in the treatment of UC were searched in seven databases:PubMed,Embase,Web of Science,CBM,CNKI,Wanfang Database,and VIP Database from January 1,2013 to June 6,2022,and the data were analyzed using RevMan 5.3 software.A total of 18 studies involving 1514 UC patients were included.Meta analysis results showed that compared with conventional Western medicine,Chinese medicine enema had a significant effect on UC,and the clinical effective rate of the experimental group using Chinese medicine enema was 4.45 times that of the control group using conventional Western medicine(odds ratio=4.45,95%confidence interval[3.27,6.06]).Therefore,Chinese medicine enema is effective in the treatment of UC,and can significantly reduce related symptoms.

Kangfuxin Fluid on the Treatment of Ulcerative Colitis with Retention Enema： a Systematic Review

Objective： To systematically evaluate the effectiveness of Kangfuxin Fluid （KFX） in Ulcerative Colitis （UC） with retention enema. Methods： We searched The Cochanrane Library, Pubmed, EMbase, VIP, CNKI, CBM and WanFang Data from inception to December.2017, and retrospectively incorporated into the literature reference. And a systematic review of randomized controlled trials was performed. Meta-analysis was performed with RevMan5.3 software. Results： A total of 18 randomized controlled trials and 1417 patients were enrolled, among which 731 cases were in experimental group and 686 cases were in control group. The meta-analysis results revealed that the effectiveness of KFX on UC with retention enema was significantly superior to the controlled treatment （RR=1.22 95%CI： [1.16,1.27], Z=8.14, p〈0.00001）. And, the score of quality of life was significantly increased after KFX treatment （MD=11.12, 95% CI [7.00, 15.23], Z=5.30, p〈0.00001）. Conclusion： KFX on the treatment of UC with retention enema is potentially effective to improve patient＇s quality of life, and it is worth being popularized clinically. Depth researches and high quality randomized controlled trials on the efficacy of UC are necessary.

Clinical Study on the Retention Enema with Modified Dahuang Mudan Decoction in Treating Lower-Jiao Obstruction Syndrome Caused by Severe Pneumonia Complicated with Heart Failure

[Objectives]To treat patients with Lower-Jiao Obstruction Syndrome caused by severe pneumonia complicated with heart failure using the retention enema with Modified Dahuang Mudan Decoction,and to observe the effect and safety of this treatment on inflammatory indicators,cardiac function,gastrointestinal function and multiple organ failure in patients with Lower-Jiao(lower energizer)Obstruction Syndrome caused by severe pneumonia complicated with heart failure.[Methods]54 patients with Lower-Jiao Obstruction Syndrome caused by severe pneumonia complicated with heart failure diagnosed in Nanchong Chinese Medicine Hospital from January 2020 to December 2021 were randomly divided into experimental group(n=27)and control group(n=27).The control group was given conventional treatment combined with 0.9%sodium chloride injection(100 mL)+glycerine enema(40 mL).The treatment group was treated with Modified Dahuang Mudan Decoction on the basis of conventional treatment for 7 d.The efficacy indicators and adverse events such as white blood count(WBC),C-reactive protein(CRP),procalcitonin(PCT),N-terminal pro-brain natriuretic peptide(NT-proBNP),Lausanne Intestinal Failure Estimation(LIFE)and multiple organ dysfunction score(MODS)were observed.[Results](i)There was no significant difference in WBC,PCT,CRP and NT-proBNP between the two groups before treatment.All indicators after treatment were significantly lower than those before treatment in both groups(P<0.05).The levels of WBC,PCT and CRP in the treatment group were lower than those in the control group after treatment(P<0.05),and there was no significant difference in NT-proBNP between the two groups after treatment(P>0.05),but the difference in NT-proBNP before and after treatment in the treatment group was higher than that in the control group.(ii)The LIFE of the two groups decreased significantly after treatment,and the improvement of LIFE of the treatment group was better than that of the control group(P<0.05).(iii)The MODS of the two groups decreased significantly after treatment(P<0.05),and the degree of decrease after treatment in the treatment group was higher than that in the control group(P<0.05).(iv)There was no significant difference in all-cause mortality between the two groups(P>0.05).(v)No serious adverse events were found in both groups during the treatment period.[Conclusions]The conventional treatment,combined with the retention enema with Modified Dahuang Mudan Decoction could further reduce the inflammatory indicators,improve cardiac function,improve intestinal function and organ function,and the safety was good.

A Meta-Analysis of Treating Radiation Proctitis by Retention Enema with Integrated Traditional Chinese and Western Medicine

Objective:To systematically and objectively evaluate clinical efficacy of retention enema with integrated traditional Chinese and western medicine on radiation proctitis(RP).Methods:CNKI,WANFANG,VIP,CMB and foreign language databases like Embase,Central and Medline were searched.Search dates were from establishment of the databases until May 2020.Randomized controlled trials(RCTs)of retention enema with integrated traditional Chinese and western medicine for RP were retrieved.Two system reviewers selected literature materials,extracted literature data,and evaluated the quality of the literatures.RevMan 5.3 software was used for data analysis.Results:A total of 12 studies were included,including 941 patients.Meta-analysis results showed:Clinical efficacy in the retention enema group with integrated traditional Chinese and western medicine was better than that in the simple western medicine enema or blank enema group(OR=5.96,95%CI[5.50,14.29],P<0.00001).Improvement of abdominal pain in the retention enema group with integrated traditional Chinese and western medicine was better than that in the control group(MD=-0.57,95%CI[-0.72,-0.42],P<0.00001).Treatment for hematochezia in the retention enema group with integrated traditional Chinese and western medicine was better than that in the control group(MD=-0.55,95%CI[-0.69,-0.42],P<0.00001).Improvement of diarrhea in the retention enema group with integrated traditional Chinese and western medicine was better than that in the control group(MD=-0.69,95%CI[-0.91,-0.48],P<0.00001).KPS scores in the retention enema group with integrated traditional Chinese and western medicine were better than those in the control group(MD=11.91,95%CI[3.81,20.01],P<0.00001).Conclusion:Clinical efficacy of retention enema with integrated traditional Chinese and western medicine on RP is better than simple western medicine enema or blank enema.Due to the low quality of the included clinical literatures,it is necessary to carry out more deliberate,detailed,high-quality,randomized,double-blind,and multi-center RCTs in order to give more powerful demonstration on its clinical efficacy on RP.

针刺结合中药保留灌肠对溃疡性结肠炎的疗效及免疫功能的影响

目的:探讨针刺结合中药保留灌肠治疗溃疡性结肠炎(UC)的临床疗效及其改善免疫功能的作用。方法:选取符合纳入标准的UC患者70例,依据随机数字表随机分为观察组和对照组,各35例。对照组给予美沙拉嗪缓释片,观察组在对照组基础上加用针刺与中药保留灌肠疗法,两组均治疗8周。比较两组患者治疗前后血清免疫功能指标CD3^(+)、CD4^(+)与CD8^(+)含量、炎症因子指标白细胞介素(IL)-1β、IL-23与转化生长因子-β1(TGF-β1)的改善情况。结果:治疗后,两组患者TGF-β1、CD3^(+)、CD4^(+)含量均较治疗前明显升高(P<0.05),IL-1β、IL-23、CD8^(+)含量下降(P<0.05);且观察组治疗后TGF-β1、CD3^(+)和CD4^(+)水平均高于对照组(P<0.05),IL-1β、IL-23、CD8^(+)水平均低于对照组(P<0.05)。结论:针刺结合中药保留灌肠治疗能显著改善UC患者免疫功能,降低其炎症因子水平。

中药保留灌肠联合芒硝外敷的辨证施护治疗急性胰腺炎的效果

目的探讨中药保留灌肠联合芒硝外敷的中医辨证施护在急性胰腺炎患者中的应用效果。方法将80例急性胰腺炎患者随机分为观察组与对照组,对照组给予常规治疗护理,观察组在对照组基础上给予中药保留灌肠联合芒硝外敷的中医辨证施护治疗,观察两组的治疗效果及临床症状改善时间。结果观察组总有效率为97.5%(39/40),高于对照组的70.0%(28/40)(P<0.05)。经治疗,观察组临床症状改善时间均短于对照组(P<0.05)。结论中药保留灌肠联合芒硝外敷的中医辨证施护在急性胰腺炎患者中的应用效果显著,预后良好,患者乐意接受此项操作,可行推广。

清化敛疡方保留灌肠联合美沙拉嗪治疗溃疡性结肠炎的临床疗效观察

目的:探讨溃疡性结肠炎(UC)患者采取清化敛疡方保留灌肠联合美沙拉嗪的治疗效果。方法:选取如皋市中医院消化科门诊和病房2022年1月—2023年9月收治的78例UC患者,按随机数字表法分为对照组和观察组,每组39例,对照组应用美沙拉嗪治疗,观察组另加用清化敛疡方保留灌肠治疗,两组均治疗4周,对比两组临床疗效、中医证候积分、结肠镜积分、结肠黏膜病变积分、血沉、C-反应蛋白(CRP)水平及不良反应的变化。结果:与对照组相比,观察组总有效率更高(P<0.05)。治疗4周后,两组中医证候积分、结肠镜积分、结肠黏膜病变积分、血沉、CRP水平明显下降(P<0.01),且观察组低于对照组(P<0.01)。两组不良反应发生情况对比,差异无统计学意义(P>0.05)。结论:对UC患者采取清化敛疡方保留灌肠联合美沙拉嗪治疗效果显著,可明显改善结肠镜积分、结肠黏膜病变积分,减轻炎症程度和中医证候积分,不良反应发生率较低。

清肾颗粒联合中药保留灌肠治疗非透析慢性肾脏病疗效观察

目的:观察清肾颗粒联合中药保留灌肠对非透析慢性肾脏病(CKD)3~5期患者的疗效,并探究其对患者营养状况及钙磷水平的影响。方法:采用清肾颗粒联合黄苓解毒泄浊颗粒保留灌肠治疗非透析CKD 3~5期患者,并设对照组和治疗组,观察临床疗效以及中医证候积分、营养状况改善情况(血清白蛋白、血红蛋白)、钙磷代谢情况(钙、磷等)指标。结果:治疗组和对照组的临床疗效分别为67.5%(27/40)和35%(14/40),治疗组疗效显然胜于对照组(P<0.05);且与对照组比较,治疗组的营养状态和钙磷代谢都有了显著的提高,具有显著的差异。(P<0.05)。结论:清肾颗粒结合中药保留灌肠能缓解非透析CKD 3~5期患者的临床症状,改善其营养状况和钙磷水平,提高临床疗效。

中药保留灌肠联合多西环素对慢性子宫内膜炎患者的临床研究

目的:观察中药保留灌肠联合多西环素治疗慢性子宫内膜炎(CE)患者的临床效果。方法:将连云港市妇幼保健院2021年1月—2023年1月收治的60例CE患者以随机数字表法分为试验组、对照组,各30例。试验组给予中药保留灌肠联合多西环素治疗,对照组仅给予多西环素治疗,比较两组疗效、中医症候积分、子宫内膜情况、免疫组化白细胞分化抗原38(CD38)、白细胞分化抗原138(CD138)阳性率及胚胎种植成功率。结果:试验组治疗总有效率(96.67%)高于对照组(76.67%),差异有统计学意义(P<0.05);两组治疗前中医症候积分、子宫内膜厚度及免疫组化CD38、CD138阳性率比较,差异均无统计学意义(P>0.05);治疗后,两组中医症候积分均降低,试验组低于对照组,差异均有统计学意义(P<0.05);两组治疗后子宫内膜厚度均提高,试验组高于对照组,差异均有统计学意义(P<0.05);两组治疗后免疫组化CD38、CD138阳性率均降低,试验组均低于对照组,差异均有统计学意义(P<0.05);试验组胚胎种植成功率(46.67%)高于对照组(20.00%),差异有统计学意义(P<0.05)。结论:针对CE患者以中药保留灌肠联合多西环素治疗临床效果显著,可进一步缓解患者症状,改善子宫内膜厚度,降低免疫组化CD38、CD138阳性率,提高患者胚胎种植成功率。

保肾排毒方联合乌蕨汤保留灌肠对慢性肾脏病3~5期患者的临床疗效

目的 探讨保肾排毒方联合乌蕨汤保留灌肠对慢性肾脏病3~5期患者的临床疗效。方法 80例患者随机分为对照组和观察组,每组40例,对照组给予常规治疗,观察组在对照组基础上加用保肾排毒方联合乌蕨汤保留灌肠,疗程8周。检测临床疗效、炎性因子(CRP、IL-6、TNF-α)、肾功能指标(BUN、Scr、β2-MG、PTH)、中医证候评分、不良反应发生率变化。结果 观察组总有效率高于对照组(P<0.05)。治疗后,2组炎性因子、肾功能指标、中医证候评分降低(P<0.05),以观察组更明显(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论 保肾排毒方联合乌蕨汤保留灌肠可安全有效地改善慢性肾脏病3~5期患者肾功能,减轻中医证候,抑制炎症反应。

基于PDCA循环法的水合氯醛保留灌肠对急诊科婴幼儿镇静睡眠效果的研究

目的分析PDCA循环法的水合氯醛保留灌肠对急诊科婴幼儿的镇静睡眠效果。方法选取2021年7月至2022年8月赣州市妇幼保健院收治的80例接受水合氯醛保留灌肠治疗的婴幼儿作为研究对象,按照入院先后顺序将患儿分为观察组(40例)与对照组(40例)。对照组实施常规护理,观察组实施PDCA循环法护理。比较两组患儿镇静效果、睡眠起效时间、睡眠维持时间、灌肠外溢情况。结果观察组患儿总有效率高于对照组,差异有统计学意义(P<0.05);观察组睡眠起效时间短于对照组,差异有统计学意义(P<0.05);观察组睡眠维持时间长于对照组,差异有统计学意义(P<0.05);观察组患儿灌肠外溢占比低于对照组,差异有统计学意义(P<0.05)。结论基于PDCA循环法的水合氯醛保留灌肠,有利于提升镇静效果,睡眠起效时间和维持时间均得到改善,值得在临床应用。

益肾灌肠方保留灌肠结合微信延续护理干预对糖尿病肾病的疗效观察

目的探讨糖尿病肾病(DKD)应用益肾灌肠方保留灌肠结合微信延续护理干预的效果。方法采用随机数字表法将2020年1月至2022年10月本院收治的90例DKD患者分为三组,每组各30例。对照组1组采用厄贝沙坦+微信延续护理干预,对照2组仅采用厄贝沙坦干预,实验组采用益肾灌肠方保留灌肠+微信延续护理干预,均干预4周。对比三组临床疗效、血糖水平、尿微量白蛋白(mALB)、血清肌酐清除率(Ccr)、中医证候积分及生活质量。结果实验组临床总有效率高于对照1组和对照2组,干预后空腹血糖(FPG)、餐后2h血糖(2hPG)、尿mALB水平及中医证候积分低于对照组1组和对照2组,血清Ccr及生活质量评分高于对照组1组和对照2组(P<0.05)。结论DKD患者应用益肾灌肠方保留灌肠结合微信延续护理干预可控制血糖水平,延缓肾功能恶化,缓解临床症状,提升患者生活质量。

低频脉冲电刺激联合桃红四物汤保留灌肠对慢性盆腔炎合并盆腔积液的疗效

目的探讨低频脉冲电刺激联合桃红四物汤保留灌肠治疗慢性盆腔炎合并盆腔积液的疗效及对血清炎性因子的影响。方法选取380例慢性盆腔炎合并盆腔积液患者,按随机数字表法分为研究组和对照组,每组190例。对照组治疗方案为西药抗炎治疗,研究组为低频脉冲电刺激联合桃红四物汤保留灌肠。比较2组实际治疗效果,血性炎性因子[D-二聚体(D-D)、超敏C-反应蛋白(hs-CRP)、白介素-6(IL-6)]水平。结果研究组总有效率高于对照组(P<0.05);2组治疗前中医证候积分比较差异无统计学意义(P>0.05);2组治疗1~4周后中医证候积分均低于本组治疗前(P<0.05);且研究组治疗后1、2、4周中医证候积分均低于对照组(P<0.05);2组治疗前症状表现比较差异无统计学意义(P>0.05),治疗后2组盆腔痛、盆腔包块、盆腔积液、附件增粗等症状均有所好转,其中研究组各症状消失或减轻人数高于对照组(P<0.05);2组治疗前炎性因子水平比较差异无统计学意义(P>0.05);治疗后,研究组D-D、hs-CRP、IL-6水平均低于对照组(P<0.05);治疗前2组患者生活质量差异无统计学意义(P>0.05),2组治疗后生活质量各维度评分均有所提升,但研究组升高幅度大于对照组(P<0.05)。结论低频脉冲电刺激联合桃红四物汤保留灌肠治疗慢性盆腔炎合并盆腔积液的疗效显著,降低患者机体的炎性因子水平,改善临床症状。

中药保留灌肠治疗慢性盆腔炎的效果分析

目的探讨中药保留灌肠治疗慢性盆腔炎的效果。方法纳入2021年1月至2022年1月就诊我院的80例女性盆腔炎病患者,将其随机分为病例组和对照组,每组各为40例,对照组使用常规口服败酱汤加减中药方进行治疗,病例组在对照组基础上再予中药保留灌肠方治疗。对比两组治疗效果、中医证候评分、炎症因子水平以及生活质量。结果经过治疗后,病例组治疗有效率高于对照组(P<0.05);两组中医证候评分及炎症因子水平均下降,且病例组低于对照组(P<0.05);治疗护理后两组患者SF-36评分均升高,且病例组高于对照组(P<0.05)。结论临床中药保留灌肠治疗慢性盆腔炎患者能够提升治疗效果,降低证候评分及炎症因子水平,提升生活质量。

肠炎宁糖浆口服联合黄连素灌肠治疗急性菌痢患儿临床研究

目的:观察肠炎宁糖浆口服联合黄连素灌肠治疗急性菌痢患儿的临床疗效。方法:选取142例急性菌痢患儿为研究对象,按随机数字表法分为对照组和试验组各71例。对照组给予黄连素灌肠治疗,试验组在对照组基础上使用肠炎宁糖浆治疗。比较2组临床症状体征控制时间、临床疗效及不良反应,比较2组治疗前后超敏C-反应蛋白(hs-CRP)、肿瘤坏死因子-α (TNF-α)、谷丙转氨酶(ALT)、血尿素氮(BUN)水平及生活质量。结果:治疗后,试验组体温、肠鸣音恢复正常时间及腹痛消失时间均短于对照组(P<0.05)。治疗后,2组hs-CRP、TNF-α、ALT、BUN水平均降低(P<0.05),且试验组低于对照组(P<0.05)。治疗后,2组生活质量调查问卷(rhinRQLQ)各项评分均升高(P<0.05),且试验组高于对照组(P<0.05)。试验组治疗总有效率97.18%,高于对照组87.32%(P<0.05)。试验组不良反应总发生率1.41%,低于对照组9.86%(P<0.05)。结论:肠炎宁糖浆口服联合黄连素灌肠治疗急性菌痢患儿能够有效抑制血清hs-CRP及TNF-α水平,改善ALT、BUN水平,有利于患儿临床症状的恢复,且不良反应少。

湿润烧伤膏保留灌肠治愈混合痔经肛门直肠黏膜环切术后药物性肠病1例报告

给予2019年4月湖北省中医院收治的1例混合痔经肛门直肠黏膜环切术后药物性肠病患者在常规中药辨证口服治疗的基础上行湿润烧伤膏保留灌肠治疗,治疗1个月后,溃疡创面完全愈合,愈后黏膜无瘢痕增生,肠腔无狭窄。

中药保留灌肠联合益脾理肠汤内服治疗慢性结肠炎的效果及对炎症反应的影响

目的分析中药保留灌肠联合益脾理肠汤内服治疗慢性结肠炎的临床价值。方法以2018年1月至2022年1月收治的86例慢性结肠炎患者为研究对象,根据随机数字表法将其分为对照组(n=43,常规治疗)和研究组(n=43,常规治疗+中药保留灌肠+益脾理肠汤内服)。比较两组的治疗效果。结果研究组的治疗总有效率显著高于对照组(P<0.05)。治疗后,研究组的内毒素(BT)、D-乳酸(D-LA)及二胺氧化酶(DAO)水平显著低于对照组(P<0.05)。治疗后,研究组的肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、细胞间黏附分子-1(ICAM-1)、基质金属蛋白酶-9(MMP-9)及中性粒细胞明胶酶相关脂质运载蛋白(NGAL)水平显著低于对照组(P<0.05)。治疗后,研究组的CD3^(+)、CD4^(+)及CD4^(+)/CD8^(+)高于对照组,CD8^(+)低于对照组(P<0.05)。结论中药保留灌肠联合益脾理肠汤内服治疗慢性结肠炎的效果显著,有助于控制机体炎症反应,改善免疫功能,进而促进肠黏膜屏障功能恢复,值得推广。

竹圈盐灸联合中药保留灌肠治疗溃疡性结肠炎的疗效观察及对细胞因子的影响

目的:探讨竹圈盐灸联合中药保留灌肠治疗溃疡性结肠炎(UC)的疗效及对细胞因子的影响。方法:采用随机数字表法将2021年1月—2023年1月收治的120例UC患者分为对照组、中药保留灌肠组和综合治疗组,每组40例。对照组采用常规西药治疗,中药保留灌肠组采用常规西药+中药保留灌肠治疗,综合治疗组采用常规西药+中药保留灌肠+竹圈盐灸治疗,三组均连续治疗4周。对比三组临床疗效、细胞因子水平、电子结肠镜评分、中医症候积分、不良反应和复发率。结果:综合治疗组的总有效率高于对照组和中药保留灌肠组,中药保留灌肠组高于对照组(P<0.05)。治疗后,综合治疗组白介素-1β(IL-1β)、白介素-8(IL-8)水平及电子结肠镜评分、中医症候积分低于对照组和中药保留灌肠组,且中药保留灌肠组低于对照组(P<0.05)。三组未见明显不良反应。综合治疗组和中药保留灌肠组复发率比较,差异无统计学意义(P>0.05),但综合治疗组复发率显著低于对照组(P<0.05)。结论:竹圈盐灸联合中药保留灌肠治疗UC安全有效,可减轻炎症反应、肠黏膜病变程度,降低复发率。

季氏复方马齿苋液保留灌肠预防混合痔术后切口感染临床研究

目的:观察季氏复方马齿苋液预防混合痔术后切口感染的临床效果。方法:选取60例湿热下注或气滞血瘀的混合痔患者,采用随机数字表法分为对照组和试验组各30例。对照组给予0.5%甲硝唑氯化钠注射液保留灌肠,试验组给予季氏复方马齿苋液保留灌肠。比较2组术后体温、手术切口感染征象、血清白细胞介素-10(IL-10)水平以及临床疗效。结果:2组术后临床疗效均为100%。术后第2、3、4天,2组体温比较,差异均无统计学意义(P>0.05),且2组体温均处于正常范围,均未出现37℃以上的发热患者。术后,2组均无出现红、肿、热、痛及脓性分泌物等感染征象。术后第3天,试验组平均IL-10(1.32±1.30)pg/mL,对照组为(1.45±1.65)pg/mL,2组比较,差异无统计学意义(P>0.05)。结论:季氏复方马齿苋液和0.5%甲硝唑氯化钠注射液,在预防混合痔术后感染方面疗效肯定,并起到相近效果,患者均无出现感染、发热、发炎等征象。

柴枳败酱汤保留灌肠联合中药贴敷治疗小儿肠系膜淋巴结炎的效果研究

目的 研究分析小儿肠系膜淋巴结炎采用中药贴敷联合柴枳败酱汤保留灌肠治疗的临床价值。方法选择2021年6月至2022年7月北京中医药大学深圳医院(龙岗)收治的180例小儿肠系膜淋巴结炎患儿为研究对象,根据随机数表法将其分为西医对照组(n=60)、中药灌肠治疗组(n=60)、灌肠+中药贴敷组(n=60),分别行西医解痉、抗炎治疗,柴枳败酱汤保留灌肠治疗,灌肠+中药贴敷治疗,比较三组的治疗有效率、中医证候积分以及淋巴结大小。结果 灌肠+中药贴敷组的治疗总有效率高于西医对照组和中药灌肠治疗组,差异有统计学意义(P <0.05)。治疗前,三组中医证候积分、淋巴结大小比较,差异无统计学意义(P> 0.05);治疗后,灌肠+中药贴敷组的舌苔异常、大便异常、纳呆食少、脘腹胀满、腹痛评分均低于西医对照组和中药灌肠治疗组,差异有统计学意义(P <0.05);灌肠+中药贴敷组的淋巴结横径和纵径均小于西医对照组和中药灌肠治疗组,差异有统计学意义(P <0.05)。结论 在小儿肠系膜淋巴结炎的临床治疗中,通过联合运用中药贴敷与柴枳败酱汤保留灌肠,可以使淋巴结纵、横径缩小,改善症状,从而提高治疗效果。